FDA recall Z-1652-2022

Qiagen Sciences LLC · Class II · device

Product

FGFR RGQ RT-PCR Kit (RUO, not IVD) REF 8747010

Reason for recall

Increased occurrence rate of false positive results, lead to a false positive sample result that could subsequently be incorrectly reported from the laboratory. A false positive result could lead to the risk of the patient being exposed to an inappropriate or suboptimal anti-cancer treatment and/or unnecessarily experiencing side effects

Distribution

IN, NC, MN, TX Foreign: Belgium, China, Germany, Jordan, Italy, Netherlands, Malaysia, Spain, Thailand

Key facts

Status
Ongoing
Initiation date
2022-07-20
Report date
2022-09-07
Voluntary/Mandated
Voluntary: Firm initiated
Location
Germantown, MD, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-1652-2022